Advertisement
Screener

WEST PHARMACEUTICAL SERVICES, INC. (WST) Payments to Acquire Other Investments

2.3 / 5 stars · 56/120 Roast Me

WEST PHARMACEUTICAL SERVICES, INC. Payments to Acquire Other Investments

WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Payments to Acquire Other Investments of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireOtherInvestments · last filed 2019-02-28

  • WEST PHARMACEUTICAL SERVICES, INC. payments to acquire other investments for the quarter ending 2017-12-31 was $0.00.
  • WEST PHARMACEUTICAL SERVICES, INC. payments to acquire other investments for the quarter ending 2017-09-30 was $0.00.
  • WEST PHARMACEUTICAL SERVICES, INC. payments to acquire other investments for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
  • WEST PHARMACEUTICAL SERVICES, INC. payments to acquire other investments for the quarter ending 2016-09-30 was $0.00.
  • WEST PHARMACEUTICAL SERVICES, INC. payments to acquire other investments for fiscal 2018 was $0.00.
  • WEST PHARMACEUTICAL SERVICES, INC. payments to acquire other investments for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
  • WEST PHARMACEUTICAL SERVICES, INC. payments to acquire other investments for fiscal 2016 was $8.40M, a 460.00% increase from fiscal 2015.
  • WEST PHARMACEUTICAL SERVICES, INC. payments to acquire other investments for fiscal 2015 was $1.50M, a 200.00% increase from fiscal 2014.
Period endPayments to Acquire Other Investments 3 monthPayments to Acquire Other Investments 6 monthPayments to Acquire Other Investments 9 monthPayments to Acquire Other Investments 12 month
2018-12-31$0.00
10-K · filed 2019-02-28
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$0.00
derived: sum of 2 quarters · filed 2019-02-28
$0.00
10-K · filed 2019-02-28
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
$0.00
10-Q · filed 2017-10-31
2017-06-30$0.00
10-Q · filed 2017-08-01
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$0.00
derived: sum of 2 quarters · filed 2019-02-28
$8.40M
derived: sum of 3 quarters · filed 2019-02-28
$8.40M
10-K · filed 2019-02-28
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
$8.40M
derived: sum of 2 quarters · filed 2017-10-31
$8.40M
10-Q · filed 2017-10-31
2016-06-30$8.40M
10-Q · filed 2016-10-31
$8.40M
10-Q · filed 2017-08-01
2015-12-31$1.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$1.50M
derived: sum of 2 quarters · filed 2018-02-26
$1.50M
10-K · filed 2018-02-26
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31
$0.00
10-Q · filed 2016-10-31
2015-06-30$0.00
10-Q · filed 2016-08-01
2014-12-31$500.00K
10-K · filed 2017-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
DEXCOM INC (DXCM)United States$33.004B25.42
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44